Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 717530, 12 pages
http://dx.doi.org/10.1155/2015/717530
Review Article

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme

1Department of Neurology, The First Hospital, Shanxi Medical University, No. 85 South Jie Fang Road, Taiyuan, Shanxi 030001, China
2Department of Neurosurgery, The First Hospital, Shanxi Medical University, No. 85 South Jie Fang Road, Taiyuan, Shanxi 030001, China

Received 25 September 2014; Accepted 8 January 2015

Academic Editor: Yung-Fu Chang

Copyright © 2015 Liu Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Jun Yang, Yan Li, Tianlu Zhang, and Xin Zhang, “Development of bioactive materials for glioblastoma therapy,” Bioactive Materials, vol. 1, no. 1, pp. 29–38, 2016. View at Publisher · View at Google Scholar
  • Jinling Liu, Shu Wei, Lixia Liu, Fengping Shan, Yujun Zhao, and Guoshun Shen, “The role of porcine reproductive and respiratory syndrome virus infection in immune phenotype and Th1/Th2 balance of dendritic cells,” Developmental & Comparative Immunology, 2016. View at Publisher · View at Google Scholar
  • Alcedo-Guardia, Labat, Blas-Boria, and Vivas-Mejia, “Diagnosis and new treatment modalities for Glioblastoma: Do they improve patient survival?,” Current Molecular Medicine, vol. 16, no. 5, pp. 447–464, 2016. View at Publisher · View at Google Scholar
  • Tiffany R Hodges, Sherise D Ferguson, and Amy B Heimberger, “Immunotherapy in glioblastoma: emerging options in precision medicine,” CNS Oncology, 2016. View at Publisher · View at Google Scholar
  • Xuxu Xu, Yan Gao, Fengping Shan, and Juan Feng, “A novel role for RGMa in modulation of bone marrow-derived dendritic cells maturation induced by lipopolysaccharide,” International Immunopharmacology, vol. 33, pp. 99–107, 2016. View at Publisher · View at Google Scholar
  • Jason Miska, Aida Rashidi, Alan L. Chang, Megan E. Muroski, Yu Han, Lingjiao Zhang, and Maciej S. Lesniak, “Anti-GITR therapy promotes immunity against malignant glioma in a murine model,” Cancer Immunology, Immunotherapy, vol. 65, no. 12, pp. 1555–1567, 2016. View at Publisher · View at Google Scholar
  • Hongyu Liu, Ling Chen, Jialin Liu, Hengxing Meng, Rong Zhang, Lin Ma, Liangliang Wu, Songyan Yu, Fei Shi, Ying Li, Lijun Zhang, Lingxiong Wang, Shiyu Feng, Qi Zhang, Yaojun Peng, Qiyan Wu, Chunxi Liu, Xin Chang, Lin Yang, Xinguang Yu, and Tianyi Liu, “Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma,” Cancer Letters, 2017. View at Publisher · View at Google Scholar
  • Keiichi Sakai, Shigetaka Shimodaira, Shinya Maejima, Kenji Sano, Yumiko Higuchi, Terutsugu Koya, Haruo Sugiyama, and Kazuhiro Hongo, “Clinical effect and immunological response in patients with advanced malignant glioma treated with WT1-pulsed dendritic cell-based immunotherapy: A report of two cases,” Interdisciplinary Neurosurgery, vol. 9, pp. 24–29, 2017. View at Publisher · View at Google Scholar
  • Ana Miranda, María Blanco-Prieto, João Sousa, Alberto Pais, and Carla Vitorino, “Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches,” International Journal of Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Jeremy Tetsuo Miyauchi, and Stella E. Tsirka, “Advances in immunotherapeutic research for glioma therapy,” Journal of Neurology, 2017. View at Publisher · View at Google Scholar
  • Jiri Polivka, Tereza Kubikova, Inka Treskova, Lubos Holubec, Vladimir Priban, Ondrej Hes, and Kristyna Pivovarcikova, “Advances in experimental targeted therapy and immunotherapy for patients with glioblastoma multiforme,” Anticancer Research, vol. 37, no. 1, pp. 21–33, 2017. View at Publisher · View at Google Scholar
  • Yi-Feng Miao, Tao Lv, Ran Wang, Hui Wu, Shao-Feng Yang, Jiong Dai, and Xiao-Hua Zhang, “CpG and transfer factor assembled on nanoparticles reduce tumor burden in mice glioma model,” RSC Adv., vol. 7, no. 19, pp. 11644–11651, 2017. View at Publisher · View at Google Scholar
  • Jianlong Li, Meng Chen, Lingchao Chen, Chuanlu Jiang, Feng Wang, Guangzhi Wang, Ying Sun, Jinquan Cai, Xing Liu, Junhe Zhang, Xiaoyan Lu, and Yongli Li, “Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells,” Oncotarget, vol. 8, no. 16, pp. 26256–26268, 2017. View at Publisher · View at Google Scholar
  • Edouard Alphandéry, “Glioblastoma Treatments: An Account of Recent Industrial Developments,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Chia-Ing Jan, Wan-Chen Tsai, Horng-Jyh Harn, Woei-Cherng Shyu, Ming-Chao Liu, Hsin-Man Lu, Shao-Chih Chiu, and Der-Yang Cho, “Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Davide Schiffer, Laura Annovazzi, Cristina Casalone, Cristiano Corona, and Marta Mellai, “Glioblastoma: Microenvironment and Niche Concept,” Cancers, vol. 11, no. 1, pp. 5, 2018. View at Publisher · View at Google Scholar